COO

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Cooper Companies, Inc.

CooperCompanies ("Cooper") is a global medical device company. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries.
CEO
Albert White
Employees
12000
Headquarters

6101 Bollinger Canyon Rd Ste 500
San Ramon, California 94583
Phone: 19254603600
www.coopercos.com

News

Baron Funds Sees Bright Future in Cooper Companies (COO)
Aug 18, 2022 03:54am

Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2022 investor letter – a copy of which can be downloaded here. In the quarter ended June 30, 2022, Baron Health Care Fund (the “Fund”) declined 10.00% (Institutional Shares), compared with the 7.43% decline for the Russell 3000 Health Care Index (the […]


Source:Insider Monkey
The Cooper Companies – Consensus Indicates Potential 30.0% Upside
Jul 26, 2022 10:53am

The Cooper Companies found using ticker (COO) have now 12 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 560 and 310 with a mean TP of 407.58. Given that the stocks previous close was at 313.44 this would indicate that there is a potential upside of 30.0%. There is a 50 day moving average of 322.01 and the 200 day MA is 381.14. The market capitalisation for the company is $15,477m. Find out more information at: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $20,126m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.


Source:DirectorsTalk
Ex-Dividend Reminder: Fastenal, Cooper Companies and AptarGroup
Jul 22, 2022 14:05pm

Looking at the universe of stocks we cover at Dividend Channel, on 7/26/22, Fastenal Co. (Symbol: FAST), Cooper Companies, Inc. (Symbol: COO), and AptarGroup Inc. (Symbol: ATR) will all trade ex-dividend for their respective upcoming dividends. Fastenal Co. will pay its quarte


Source:Nasdaq
The Cooper Companies – Consensus Indicates Potential 38.9% Upside
Jul 19, 2022 12:43pm

The Cooper Companies with ticker code (COO) now have 12 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 560 and 310 and has a mean target at 407.58. Given that the stocks previous close was at 293.51 this indicates there is a potential upside of 38.9%. The day 50 moving average is 323.55 while the 200 day moving average is 383.71. The market capitalisation for the company is $14,512m. Company Website: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $20,152m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.


Source:DirectorsTalk
The Cooper Companies declares $0.03 dividend
Jul 13, 2022 20:18pm

The Cooper Companies (NYSE:COO) declares $0.03/share semi-annual dividend, in line with previous.Forward yield 0.02%Payable Aug.


Source:Seeking Alpha
The Cooper Companies – Consensus Indicates Potential 34.5% Upside
Jul 05, 2022 12:22pm

The Cooper Companies with ticker code (COO) have now 11 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 560 and 335 with the average target price sitting at 421. With the stocks previous close at 313.12 this is indicating there is a potential upside of 34.5%. There is a 50 day moving average of 338.25 and the 200 day moving average is 390.21. The company has a market cap of $15,714m. Find out more information at: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $21,128m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.


Source:DirectorsTalk
The Cooper Companies – Consensus Indicates Potential 33.4% Upside
Jun 21, 2022 12:21pm

The Cooper Companies found using ticker (COO) have now 11 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 535.57 and 320.38 calculating the mean target price we have 406.98. With the stocks previous close at 305.16 this would imply there is a potential upside of 33.4%. The day 50 moving average is 355.13 and the 200 day MA is 396.27. The company has a market cap of $15,045m. Find out more information at: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $20,064m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.


Source:DirectorsTalk